Literature DB >> 34956948

Systematic review and meta-analysis of hospital acquired infections rate in a middle east country (1995-2020).

Mohammad Khammarnia1, Alireza Ansari-Moghaddam1, Eshagh Barfar1, Hossein Ansari1, Azar Abolpour2, Fatemeh Setoodehzadeh1, Javad Shahmohammadi3.   

Abstract

Background: Hospital-acquired infections (HAIs) are a global problem in hospitals and significant causes of mortality and morbidity regardless of advances in supportive care, antimicrobial therapy and prevention. The study aimed to determine a comprehensive estimate of the HAIs prevalence, influential factors, and types of these infections in Iran.
Methods: A systematic literature review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using the online databases; Medline, EMBASE, Scopus, Cochrane, SID, Magiran, and Medlib from January 1995 to September 2020 using a combination of medical subject heading terms ('Nosocomial infection [Mesh] OR '' Hospital infection [Mesh] OR Hospital Acquired Infection[Mesh] OR Healthcare-associated infection ''AND ('Iran' [Mesh]) among observational and interventional studies. SPSS version 25 and STATA version 11 were used for data analysis.
Results: A total of 66 (cross-sectional, cohort, and case-control) observational studies were identified. More of the studies had been done before 2014(43 papers or 65%). Based on the random-effects model, the overall prevalence of HAIs in Iran was 0.111 [95% CI: 0.105 - 0.116] with a high, statistically significant heterogeneity (I2= 99.9%). The infection rate was 0.157 and 0.089 before and after the Iranian Health Transformation Plan (HTP), respectively. HAIs rates reported more in the South and West of Iran rather than other regions (0.231 and 0.164) (p= 0.001). Escherichia coli and klebsiella infections were reported in 53 and 52 papers (0.239 and 0.180, respectively). In addition, respiratory and urinary infections were reported 0.296 and 0.286 in 51 and 38 papers, respectively.
Conclusion: The prevalence of HAIs in Iran is relatively high. Preventing and decreasing hospital nosocomial infections can considerably affect reducing mortality and health-related costs. This should be taken into consideration by health policymakers for pathology and revision of some previous programs and standards as well as the development of appropriate and evidence-based control and education programs to reduce this health problem.
© 2021 Iran University of Medical Sciences.

Entities:  

Keywords:  Hospital; Hospital infection; Iran; Meta-analysis; Nosocomial infection

Year:  2021        PMID: 34956948      PMCID: PMC8683797          DOI: 10.47176/mjiri.35.102

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


↑What is “already known” in this topic:

Hospital-acquired infections (HAIs) represent a serious public health concern worldwide. Increased prevalence of HAIs in some cases leads to patient’s arbitrary use of drugs, causing severe health hazards as well as significant problems such as drug resistance and death in patients.

→What this article adds:

This study aimed to update and measure the prevalence of HAIs in Iran using a meta-analytic approach. The overall prevalence of HAIs in Iran was 11.1%. The prevalence of HAIs in the South and West of Iran is high. HAIs decreased after Health Transformation Plan in Iran.

Introduction

Hospitals are the most important and costly components of health care systems. They account for more than two-thirds of health care spending. Therefore, they significantly affect the overall health care quality. Prevention of infections is part of efforts to improv e the quality of health care services that are vital to patient safety. Hospital-acquired infections (HAIs), also known as nosocomial infections (NI), remain significant causes of mortality and morbidity regardless of advances in supportive care, antimicrobial therapy and prevention. HAIs are a global problem in hospitals. The popular definition of hospital infection is an infection that happens within 48 hours after hospitalization, or three days after discharge, or 30 days after surgery. Therefore, symptoms of HAIs may occur at the time of patient's hospitalization or after discharge. According to the World Health Organization (WHO) report, hundreds of millions of people are affected by HAIs every year throughout the world. Studies showed that the HAIs rates vary worldwide. In high-income countries, HAIs prevalence in hospitalized patients was 7.6%. This figure was 10.1% (varied from 5.7% to 19.1%) in low-and middle-income countries. Annually, roughly 2 and 4.5 million HAIs are reported in the United States (US) and the European Union, respectively. The infections result in 100,000 deaths and impose additional medical care costs of about $ 6.5 billion annually in the US. According to the WHO's report on 2001, hospital infection has the highest percentage in South-East Asia and the Eastern Mediterranean. Based on this report, one of the main reasons for HAIs is inadvertent misuse of antibiotics leading to widespread resistance. Unfortunately, hospitals in developing countries are hotbeds of infection transmission. These infections lead to increased mortality, longer periods of hospitalization cause emotional and mental stress, failure of surgeries, rejection of organ transplantation and a significant financial burden for healthcare systems and patients. Moreover, they are linked to the spread of multi-drug resistance (MDR) in pathogenic bacteria. The most important bacteria causing HAIs are Escherichia coli (E. coli), Klebsiella, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Enterococci. The most common nosocomial infections are urinary tract infections, surgical wound infections, pneumonia, and septicemia. Risk factors of the infections for hospitalized patients are divided into two categories: unavoidable risk factors (including old age and serious underlying causes of one's hospitalization) and risk factors that can be mitigated by appropriate treatment (including a longer period of hospitalization, use of inappropriate catheters, excessive use of broad-spectrum, prolonged use of fixed catheters, and improper hand hygiene by healthcare workers). Prevention of hospital infections is a key way to improve the quality of healthcare. Detailed information on the extent of these infections is essential for evaluating current infection prevention activities and planning for further intervention in the hospitals nationally. An overall review of the documents shows that the reported incidence of all types of HAIs in Iran is very different; so a systematic review of all the documents and their combinations can provide a complete picture of the dimensions of this problem in Iranian society, as well as increase the use of the best and the highest quality documents available. In fact, the purpose of this study was to determine a comprehensive estimate of the prevalence of HAIs, affective factors, and types of these infections in Iran. Our study updates a systematic review that was published in 2018.

Methods

A systematic and meta-analysis study was done in 2020. Relevant studies were found in PUBMED, EMBASE, SCOPUS and WEB OF SCIENCES as international databases and Magiran, SID and Medlib as Persian databases from 1995 to September 2020. The following search terms were used: (‘Nosocomial infection [Mesh] OR ‘’ hospital infection [Mesh] OR Hospital acquired infection [Mesh] OR health care associated infection ‘’AND (‘Iran’ [Mesh]). Also, the reference of identifies papers were studied and if their title were in line with the topic, they were investigated by the authors. The searches were done from July to September 2020. The observational studies (cohorts, case-control, and cross-sectional) both in English and Persian Language were investigated. Inclusion criteria were: 1) population-based observational studies reporting the prevalence of HAIs, 2) cross-sectional, retrospective and case-control studies, and 3) relevant studies with clear and detailed data. Also, case reports, case series, editorials, letters to the editor, commentaries, reviews and clinical trials as well as studies that were not calculating the prevalence of HAIs, were excluded. Abstract of all papers were imported into Endnote software version 16 then the duplicates were removed. After that, the authors read the full text, and if they had the inclusion criteria, they were kept for more investigation. Also, the review and editorial articles were excluded. The checklist was prepared by examining the content of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The PRISMA Statement comprises a 27-item checklist and a four-phase flow diagram. The checklist includes items considered essential for the transparent reporting of a systematic review. In this Explanation and Elaboration document, the meaning and rationale for each checklist item were explained. For each item, an example of good reporting was included and, anywhere possible, reference to pertinent empirical studies and methodological literature. In the next stage, we checked the results of the papers. If they had reported the rate of nosocomial infection, they were kept as the final suitable papers for analysis.

Data extraction

A data sheet was created in the Excel software and imported the data of suitable variables. The extracted data were as follows: title, year of the study, HAIs rate, gender of patients, type of infection and bacteria, setting, type of hospital, and sample size. The search generated a total of 1320 records, of which 602 papers were duplicated, and 718 titles and abstracts were reviewed. The most fundamental reasons for omission were: studies conducted outside Iran, publication type, and studies not reporting HAIs’ rate. A total of 66 articles were included in the meta-analysis and data were extracted. Supplementary information can be accessed in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009 flow diagram ( ). Also, for assessing the risk of bias, we used ROBVIS as a web app designed for visualizing risk-of-bias.

Data analysis

Data imported into the STATA software version 11 for analysis. To identify the pooled prevalence, the stochastic DerSimonian-Laird model was applied, computing the effect size with its 95% confidence interval (CI) and pictorially representing it through a Forest plot. Combined estimates were obtained for the HAIs’ overall and in detail by means of random effect models. RR Pooled data were used for the data analysis and mean instruction was used in STATA software. To further examine the source of heterogeneity, meta-regression analyses stratified by publication year and sample size in the hospital. Subgroup analyses were conducted based on study quality, geographic areas, sample size, year of publication, type of infection and hospital. Additionally, the possible sources of heterogeneity were examined using I2 statistics and Cochran’s Q test. Also, Begg’s Rank correlation test and Egger’s regression method were used to measure the propagation bias.

Results

Quality assessment of studies

The quality assessment of the studies was appraised by the PRISMA checklist. As shown in Figure 1. 66 studies entered to meta-analysis phase. The studies are shown in Table 1.
Fig. 1
Table 1

Characteristics of primary studies related to the prevalence of hospital infection in Iranian hospitals in the meta-analysis

AuthorYearSettingType of hospitalSample sizeHAIs rateHAIs in menHAIs in femalesQuality Study
Rastegegar lari et al.1998TehranPublic63290.532N/AN/ALow
Talebi Taher et al.2001QazvinPublic5460.041N/AN/ALow
Shojaee et al.2002ShahrekordPublic8450.049N/AN/ALow
Samadzadeh et al.2002OromeaPublic9420.049N/AN/ALow
Askarian et al.2003ShirazPublic1060.451N/AN/AMedium
Ekrami et al.2005AhwazPublic1820.769N/AN/AMedium
Sadegh Zadeh et al.2005ZanjanPublic1500.025N/AN/AHigh
Mousavian et al.2006AhwazPublic16040.044N/AN/AHigh
Qurbanalizadegan et al.2006TehranPublic68170.013N/AN/AMedium
Gorbanalizadegan et al.2006TehranPublic1550.039N/AN/AMedium
Naderi Nasab et al.2006MashhadPublic13410.039N/AN/AMedium
Nik Bakht et al 2007TabrizPublic4600.3480.3330.358Low
Ajal Loeyan et al.2007TehranPrivate2340.183N/AN/AMedium
Esmaili et al.2007TehranPublic1160.017N/AN/AMedium
Mohmmadi Mehr et al.2008TehranPublic1650.393N/AN/AMedium
Sharifi et al.2008QazvinPublic10830.052N/AN/AMedium
Ghazvini et al.2008MashhadPublic9710.033N/AN/AMedium
Oskouee et al.2009TabrizPublic1030.331N/AN/AMedium
Asgare Moghadam et al.2009TehranPublic1810.741N/AN/AMedium
Amini et al.2009TehranPrivate6910.109N/AN/AMedium
Talaie et al.2010TehranPublic5820.08N/AN/AMedium
Darvishpor et al.2010RashtPublic2700.163N/AN/AHigh
Khani et al.2011TehranPublic2560.3410.3230.359Medium
Afkhamzadeh et al.2011SanandajPublic1490.3220.2370.351Medium
Larypoor et al.2011QomPublic296310.001N/AN/ALow
Barak et al.2011TehranPublic17950.039N/AN/AMedium
Ghorbani Birgani et al.2011AhwazPublic7720.1010.1290.075Medium
Mobin et al.2012HamedanPublic3530.171N/AN/AHigh
Saedi et al.2012MashhadPublic6470.172N/AN/AMedium
Pourakbari et al.2012TehranPublic14970.034N/AN/ALow
Ghazvini et al.2012MashhadPublic9710.033N/AN/ALow
Soltani et al.2012TehranPublic4640.373N/AN/AMedium
Hashemi et al.2013HamedanPublic5740.528N/AN/ALow
Heydari Sour Shojaee et al.2013Charmahale bakhtyarePublic8480.087N/AN/AMedium
Shojaei et al.2013QomPublic126680.076N/AN/ALow
Saadat et al.2013ShirazPublic5910.149N/AN/AMedium
Abedini et al.2014KurdistanPublic3690.027N/AN/AMedium
Akhavan Tafti et al.2014YazdPublic1800.003N/AN/AMedium
Shakib et al.2014SanandajPublic7500.103N/AN/ALow
Davodi et al.2014MazandaranPublic57120.010N/AN/ALow
Makhloghi et al.2014QazvinPublic1880.196N/AN/ALow
Bijari et al.2014South KhorasanPublic397770.001N/AN/ALow
Behzadnia et al.2014MazandaranPublic345560.102N/AN/AMedium
Saeidimehr et al.2015AhwazPrivate169360.020N/AN/AMedium
Hashemizadeh et al.2015ShirazPublic22290.114N/AN/AMedium
Haje bageri et al.2015SanandajPublic1600.1520.1740.132High
Hosini et al.2016JahromPublic1890.254N/AN/AHigh
Servatyare et al.2017SanandajPublic1980.1670.1620.172Medium
Rahmanian et al.2017JahromPublic552950.002N/AN/AHigh
Shali et al.2017TehranPublic3000.035N/AN/AHigh
Farzanpour et al.2017SabzevarPublic894290.012N/AN/AMedium
Dadmanesh et al.2017TehranPublic9000.472N/AN/AHigh
Heydarpour et al.2017KermanshahPublic60000.023N/AN/AHigh
Eshrati et al.2018IranPublic70183930.012N/AN/AHigh
Ghanbari et al.2018IsfahanPublic55000.045N/AN/AMedium
Nasiri et al.2018TehranPublic111640.033N/AN/AMedium
Rahimi-Bashar et al.2018HamedanPublic103320.026N/AN/AMedium
Kohestani et al.2019TehranPublic6000030.046N/AN/ALow
Alkhudhairy et al.2019AhvazPublic3800.316N/AN/AHigh
Azimi et al.2019TehranPublic146900.077N/AN/AMedium
Piruozi et al.2019GrashPublic3000.068N/AN/AMedium
Yaqubi et al.2019RashtPublic7380.057N/AN/AHigh
Sepandi et al.2019TehranPublic145170.017N/AN/AHigh
Mansori et al.2020MashhadPublic28000.411N/AN/AHigh
Ahmadinejad et al.2020KermanPublic1970.401N/AN/AHigh
Emami et al.2020ShirazPublic34200.281N/AN/AHigh
Fig. 1. Flowchart of the present systematic review and meta-analysis As shown in Table 2, the odds ratio of hospital infections was reported 0.111 in the studies hospitals in Iran. Although Ecoli was investigated in 53 papers, it found 0.239 in the hospitals. Respiratory infections were reported 0.296 in the studies. In addition, more of the nosocomial infection was described in the South and West of Iran (0.231 and 0.164, respectively). As a result, male patients had acquired infection more than female (about 0.239 vs. 0.216).
Table 2

The results of sub-groups analysis of hospital infection in Iranian hospitals from 1995-2020

VariableNo. reportsPooled (95% CI)I2 (%)p
Quality of studies 99.9% 0.001
High160.193 (0.143-0.242)
Medium350.097 (0.089-0.106)
Low150.120 (0.104-0.137)
Time 99.9% 0.001
<2014430.157 (0.142-0.172)
>2014230.089 (0.082-0.097)
Patients' gender 99.7% >0.5
Male60.239 (0.160-0.318)
Female60.216 (0.124-0.307)
Age 99.6% >0.5
≤50440.117 (0.111-0.124)
>50220.111 (0.098- 0.123)
Sample Size 99.9% 0.001
≤ 1500420.191 (0.162-221)
> 1500240.087 (0.080-0.095
Region 99.5% 0.001
Center300.124 (0.112-0.136)
East70.083 (0.071-0.096)
North40.081 (0.017-0.142)
South70.231 (0.121-0.341)
West190.164 (0.143-0.185)
Type of Hospital 97.9% >0.5
Public630.112 (0.107-0.118)
Private30.100 (0.015-0.186)
Type of bacteria 99.9% 0.001
Staphylococcus aureus490.166 (0.151-0.182)
klebsiella520.180 (0.163-0.196)
Escherichia coli530.239 (0.212-0.266)
Type of infection 99.9% >0.5
Respiratory380.286 (0.261-0.310)
Urinary510.296 (0.255-0.337)
Overall660.111 (0.105-0.116)99.9%
Pooled estimate of HAIs in Iran is shown in Figure 2.
Fig. 2
The forest plot of the overall prevalence of nosocomial infections in Iran According to Table 3. HAIs in the south of Iran are vaired between 0.002 to 0.451.
Table 3

The overall prevalence of nosocomial infections in the south of Iran

StudyES95 % Conf. IntervalWeight
Askarian et al.0.4510.356- 0.54613.28
Ahmadinejad et al.0.4010.333-0.46913.94
Emami et al.0.2810.266-0.29614.69
Hosini et al.0.2540.192-0.31614.07
Saadat et al.0.1460.118-0.17414.59
Hashemizadeh et al.0.1140.101-0.12714.70
Rahmanian et al.0.0020.002-0.00214.72
Pooled ES0.2310.121-0.341100.00
Table 4 shows the results of the meta-regression analysis.
Table 4

Results of the meta-regression

Overall prevalence Coef.Std. Errortp
Year of publication- 0.0060.004- 1.490.141
Region 0.0080.0180.430.670
Type of hospital- 0.0700.107- 0.650.516
Egger’s test was done to evaluate publication bias (Fig. 3 & Table 5). Evidences of publication bias was found (p=0.001).
Fig. 3
Table 5

The Egger test for publication bias

Std_Effbeta coefficient.Std. Errtp95% Conf. Interval
Slope.0107469.0011129.660.001.0085242.0129696
bias13.414023.5811683.750.0016.261939 20.56611
The Egger test for publication bias

Discussion

HAIs have always been a major health problem as hospitals expand that, despite multiple attempts, no country or organization has managed to fully resolve. In this systematic review and meta-analysis, we have shown that the overall prevalence of HAIs in Iran was 0.111 (95% CI: 0.0.105 – 0.116). The previously systematic review by Ghashghaee et al.. revealed the HAIs rate in Iran was 4.5%. HAIs rates are also 10.1% (varied from 5.7% to 19.1%) in developing countries and 7.6% (varied from 3.5% to 12%) in developed countries (5). According to WHO reports, the HAIs rate is between 5% – 22% in the world. The high prevalence of HAIs in Iran highlights the need for urgent attention and implementation of a comprehensive plan to control these infections. Variations in HAI rates can, however, be due to differences in diagnostic criteria and tests for infection diagnosis, as well as differences in reporting systems and their consistency. According to the findings, the HAIs had decreased from 0.157 to 0.089 after HTP in Iran, which was statistically significant (p=0.001). This indicates that the measures taken in HTP have affected the quality of health services and reduced nosocomial infections. In this regard, Ghashghaee in his study, found that HAIs had decreased from 7.6% to 2.4% after HTP. Moreover, Braithwaite et al. in their Book in 2018 reported that In Iran, a government policy initiative called HTP was implemented to decrease inequality and improve public health coverage and reached more objectives especially patient safety. Based on our measurement, the most common bacteria causing HAIs were Escherichia coli and Klebsiella. The findings also demonstrated that respiratory infections and urinary infections were the most common HAIs. These findings are supported by studies carried out in EMRO (the Eastern Mediterranean Regional Office of the World Health Organization). Moreover, a meta-analysis study in Iran reported Klebsiella as common bacteria in HAIs. These infections are directly related to contamination of equipment, especially urinary catheters, environment and operating room personnel, and air conditioning systems, which in many developing countries is due to lack of proper equipment. Our findings showed that the male is more likely to have HAIs than the female. A similar result was reported in the systematic review study conducted in EMRO. Clinicians should be mindful of these differences and take them under consideration when managing patients with HAIs. However, one of the probable reasons could also be the lower number of women surveyed in the total papers reviewed in the present study. According to the results, the prevalence of HAIs in the south and west was more than in other regions of the country. The high rate of HAIs in some parts of the country is the characteristics of studied patients, their underlying diseases and the hospitalized ward. Most of the patients in south Iran were hospitalized in intensive care units. Moreover, Ahmadinejad declared that about 50% of the studied patients were addicts and they are prone to nosocomial infections. Monitoring and controlling HAIs is difficult, costly, and time-consuming; however, it is necessary and cost-effective. Adherence to hygiene principles and methods of microbiological diagnosis can prevent and control HAIs with lower costs. Using minimally invasive devices and methods, paying close attention to non-intravenous nutrition, preventing misuse and overuse of antibiotics, monitoring the pattern of infection, improving hospital environmental health, training personnel, and effective hand hygiene strategies are methods that can significantly reduce HAIs.

Conclusion

According to the reviewed studies, the prevalence of HAIs in Iran is relatively high. Despite the increasing development of health standards and quality development of hospitals in recent years, the prevalence findings indicate a relatively uneven trend in this development and an increase in the prevalence of HAIs in different parts of the country. This should be taken into consideration by health policymakers for pathology and revision of some previous programs and standards as well as the development of appropriate and evidence-based control and education programs to reduce this health problem in Iran. Efforts to improve the quality of nursing care, applied staff training, continuous monitoring HAIs, provision of facilities, implementation of infection control programs, prioritization of hospital wards for more stringent health measures, emphasis on preventive cares such as hand washing and appropriate training through mass media are the most important actions suggested in this regard.

Acknowledgment

Thanks to Zahedan University of Medical Sciences.

Conflict of Interests

The authors declare that they have no competing interests.
  22 in total

1.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

2.  Health care-associated infections in Iran: A national update for the year 2015.

Authors:  Babak Eshrati; Hossein Masoumi Asl; Shirin Afhami; Zahra Pezeshki; Arash Seifi
Journal:  Am J Infect Control       Date:  2018-01-09       Impact factor: 2.918

Review 3.  Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.

Authors:  Benedetta Allegranzi; Sepideh Bagheri Nejad; Christophe Combescure; Wilco Graafmans; Homa Attar; Liam Donaldson; Didier Pittet
Journal:  Lancet       Date:  2010-12-09       Impact factor: 79.321

4.  Pseudomonas infections in Tohid Burn Center, Iran.

Authors:  A Rastegar Lari; H Bahrami Honar; R Alaghehbandan
Journal:  Burns       Date:  1998-11       Impact factor: 2.744

5.  Study of the bacterial agents in nosocomial and acquired infections based on the blood culture in neonatal intensive care unit of a hospital, north east of Iran.

Authors:  Mahbobeh Naderi-Nasab; Ahmadshah Farhat; Parasto Tajzadeh; Setareh Sourosh; Mehvar Amiri
Journal:  Saudi Med J       Date:  2007-05       Impact factor: 1.484

6.  Bacterial infections in burn patients at a burn hospital in Iran.

Authors:  Alireza Ekrami; Enayat Kalantar
Journal:  Indian J Med Res       Date:  2007-12       Impact factor: 2.375

7.  Beyond the hospital infection control guidelines: a qualitative study using positive deviance to characterize gray areas and to achieve efficacy and clarity in the prevention of healthcare-associated infections.

Authors:  Anat Gesser-Edelsburg; Ricky Cohen; Adva Mir Halavi; Mina Zemach; Peter Vernon van Heerden; Sigal Sviri; Shmuel Benenson; Uriel Trahtemberg; Efrat Orenbuch-Harroch; Lior Lowenstein; Dan Shteinberg; Asher Salmon; Allon Moses
Journal:  Antimicrob Resist Infect Control       Date:  2018-10-24       Impact factor: 4.887

8.  Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah, Iran.

Authors:  Fatemeh Heydarpour; Youssef Rahmani; Behzad Heydarpour; Atefeh Asadmobini
Journal:  GMS Hyg Infect Control       Date:  2017-05-24

9.  A Framework for Conducting Meta-analysis Studies; Methodological Concerns and Recommendations.

Authors:  Aidin Aryankhesal; Meysam Behzadifar; Nicola Luigi Bragazzi; Ahmad Ghashghaee; Masoud Behzadifar
Journal:  Iran J Public Health       Date:  2018-05       Impact factor: 1.429

10.  Incentivizing hospital infection control.

Authors:  Sarah E Drohan; Simon A Levin; Bryan T Grenfell; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-11       Impact factor: 11.205

View more
  1 in total

1.  Differentiation Between Acinetobacter Baumannii Colonization and Infection and the Clinical Outcome Prediction by Infection in Lower Respiratory Tract.

Authors:  Ding-Yun Feng; Jian-Xia Zhou; Xia Li; Wen-Bin Wu; Yu-Qi Zhou; Tian-Tuo Zhang
Journal:  Infect Drug Resist       Date:  2022-09-12       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.